FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 337:168 July 17, 1997 Number 3 Next

	Since this article has no abstract, we have provided an extract of the first 100% of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Figure 1A.

View larger version (53K): [in this window] [in a new window]   Figure 1. A 50-year-old woman with metastatic breast cancer received seven courses of docetaxel at three-week intervals. After this treatment, the number and sizes of her lung metastases (the only known metastases) were unchanged. Total alopecia developed, but she experienced no nausea or loss of appetite.

 
Figure 1B.

P.H.T.J. Slee, M.D., Ph.D.
St. Antonius Ziekenhuis
3430 EM Nieuwegein, the Netherlands

This article has been cited by other articles:

• Paige, M., Bickler, P. E. (2004). Falsely Low Pulse Oximetry Values in Patients Receiving Docetaxel (Taxotere(R)). Anesth. Analg. 99: 622-623 [Full Text]  
• Minisini, A. M., Tosti, A., Sobrero, A. F., Mansutti, M., Piraccini, B. M., Sacco, C., Puglisi, F. (2003). Taxane-induced nail changes: incidence, clinical presentation and outcome. Ann Oncol 14: 333-337 [Abstract] [Full Text]